European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - meloxicam - oxicams - horses; dogs; cattle; cats; pigs; guinea pigs - cats:alleviation of mild to moderate post-operative pain and inflammation following surgical procedures, e.g. orthopaedic and soft tissue surgery.alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders.reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.cattle:for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for the relief of post-operative pain following dehorning in calves.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.dogs:alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.horses:for use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.for the relief of pain associated with equine colic.alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.pigs: for use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.for the relief of post-operative pain associated with minor soft tissue surgery such as castration.for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.guinea pigs:alleviation of mild to moderate post-operative pain associated with soft tissues surgery such as male castration.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reduction of neonatal enterotoxicosis of piglets, caused by e. coli strains, expressing the adhesins f4ab, f4ac, f4ad, f5, f6 and f41, during the first days of life.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - isoxazolines, ectoparasiticides for systemic use - dogs - treatment of flea infestation in dogs (ctenocephalides felis and c. canis)  for at least 5 weeks. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).treatment of tick infestation in dogs (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus). one treatment kills ticks for up to one month.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - pigs; cattle - novem 5-mg/ml solution for injection for cattle and pigs:cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.for use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for the relief of postoperative pain following dehorning in calves.pigsfor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation.for the relief of postoperative pain associated with minor soft-tissue surgery such as castration.novem 20-mg/ml solution for injection for cattle and pigs:cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.for use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.for the relief of postoperative pain following dehorning in calves.pigsfor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation.for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.novem 40 mg/ml solution for injection for cattle:for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - vcp1338 virus - immunostimulants, antineoplastic and immunomodulating agents, immunostimulants, - cats - immunotherapy to be used in association with surgery and radiotherapy in cats with fibrosarcoma (2-5 cm diameter) without metastasis or lymph node involvement, to reduce the risk of relapse and increase the time to relapse (local recurrence or metastasis).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - imepitoin - other antiepileptics, antiepileptics - dogs - for the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - firocoxib - anti-inflammatory and anti-rheumatic products, non-steroids - dogs - tabletsfor the relief of pain and inflammation associated with osteoarthritis in dogs.for the relief of postoperative pain and inflammation associated with soft-tissue, orthopaedic and dental surgery in dogs.oral pastealleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - west nile recombinant canarypox virus (vcp2017 virus) - immunologicals for equidae, horse, immunologicals - horses - active immunisation of horses from five months of age against west nile disease by reducing the number of viraemic horses. if clinical signs are present, their duration and severity are reduced.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - insulin human - insulins and analogues for injection, intermediate-acting - cats; dogs - for the treatment of diabetes mellitus in cats and dogs to achieve reduction of hyperglycaemia and improvement of associated clinical signs.